American College Of Surgeons - Inspiring Quality: Highest Standards, Better Outcomes

Session Code: PS317
Title: Infected Mesh: Prevention Strategies and Management
Date and Time of Session: Wednesday, October 7: 9:45 am - 11:15 am
Location: McCormick Place Convention Center - Room: W-375A
Description: The problem of mesh infection has grown as the accepted practices of incisional and ventral hernia repair include the use of mesh in almost all circumstances. This panel will discuss strategies to prevent mesh infection – patient selection, choice of appropriate mesh (synthetic vs biologic) and operative measures. The management of infected mesh is difficult – must the mesh be removed? Might it respond to antibiotic therapy? Can mesh be successfully used in contaminated wounds without subsequent infection?
CME Credit Hours: 1.5
Webcast Package Available: Yes
Audio Package Available: Yes
Trauma / Critical Care (TRA), General Surgery (GEN), Obstetrics and Gynecology (OBG)
Credit to Address Regulatory Mandates:
Patient safety, Trauma/Critical Care
Sponsored By:
Advisory Council for General Surgery
Program Participants:
B. Todd Heniford, MD, FACS
Bruce Ramshaw, MD, FACS
Speaker Patient Preparation and Operative Techniques to Prevent Mesh Infection
Jeffrey Edward Janis, MD FACS
Speaker Absorbable Synthetic Mesh and Mesh Infection Prevention - What Are They? Do They Work?
Alfredo M. Carbonell, DO, FACS, FACOS
Speaker The Use of Synthetic Mesh in Contaminated Fields: Can it Work Without Mesh Infection Consequences
Harry van Goor, MD, PhD, FRCS
Speaker Biologic Mesh in Contaminated Hernia Repair - Techniques, Outcomes, Cost Measures
Igor Belyansky, MD FACS
Speaker Treatment of Infected Mesh - Antibiotics, Surgery, and Long-Term Outcomes
Vedra Abdomerovic Augenstein, MD FACS
Moderator Questions to the Panel
B. Todd Heniford, MD, FACS